12:00 AM
 | 
Jul 22, 2010
 |  BC Innovations  |  Distillery Therapeutics

Indication: Cardiovascular disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information
Cardiovascular disease
Cerebral cavernous malformation (CCM) KRIT1 ankyrin repeat containing (KRIT1; CCM1); cerebral cavernous malformation...

Read the full 195 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >